Product & Service
Pop up
About us
Products
R&D
Certificate
News
Contact us
中文版
Oncology
Trastuzumab
Name: Trastuzumab
CAS :180288-69-1
Registration :
Structural formula:
Previous:
Osimertinib mesylate
Next:
Bevacizumab
line
Copyright(C)2020,
Hangzhou Jinlan Pharm-Drugs Technology Co., Ltd.
All Rights Reserved.